Therapeutic Drug Monitoring of Inhaled Tobramycin in a Post–Hematopoietic Cell Transplant Patient With Bronchiolitis Obliterans and End-Stage Renal Disease

There are no widely accepted dose alterations for inhaled tobramycin in the setting of renal dysfunction, and serum concentrations are not typically monitored. Herein we describe a case report of a...